Dr. Nikesh Kotecha, Vice President Informatics Parker Institute, will discuss how the informatics ecosystem is impacting the field of immunotherapy. Specifically, the bioinformatics community is advancing new methods for structural biology, including protein modeling and synthetic bio approaches, that are impacting immuno-cell therapies. Furthermore, translational bioinformatics approaches are advancing our understanding of complex data elements, including genomic data, in early stage clinical trials, as targeted and personalized therapies continue to evolve. As the need to incorporate these advanced data analytic approaches at the bedside continues to expand, there is an intense demand for pharma, health, and academic fields to work together. Furthermore, as pharma develops advanced therapies, electronic healthcare record systems (EHR), must be able to adapt to the new data elements required to manage care, including adverse event data.
Dr. Nikesh Kotecha will leverage his experience in building capabilities to support immunotherapy resources for 7 top cancer institutes (Stanford, UCLA, UCSF, MDAnderson, UPenn, Dana Farber and MSKCC ) to highlight the essential and broad role of informatics in the immunotherapy field. Dr. Kotecha works at the Parker Institute as a leader in developing strategies and resources for the broad range of informatics needs required to deliver an immunotherapy at the bedside.
After participating in this activity, the learner should be better able to:
- Evaluate data integration, transfer, and standardization needs for immunotherapy programs across institutions
- Review the key components required to sustain an informatics ecosystem capable of delivering an advanced immunotherapy at the bedside within an institution
- Analyze the current status and open challenges in the immunotherapy field that are relevant to the informatics community
Nikesh Kotecha, PhD
VP Informatics, Parker Institute for Cancer Immunotherapy
Nikesh leads the analytic and informatics efforts at the Parker Institute for Cancer Immunotherapy as VP of Informatics. The goal of the Parker Institute, an unprecedented collaboration between the country’s leading immunologists and cancer centers is to accelerate the development of breakthrough immune therapies for cancer. Nikesh also designs and leads courses on methods, approaches and analysis in an era of high throughput assays and big data as part of the Systems and Computational Immunology Program at Stanford. Prior to joining the Parker Institute, Nikesh was CEO and co-founder of Cytobank, Inc.